Gangliosides and sulfatide in cerebrospinal fluid in leukoaraiosis

Dementia and Geriatric Cognitive Disorders

Volumn 8, Issue 3, 1997, Pages 174-179

  Tarvonen Schroder S ^a   Blennow, K ^b   Lekman, A ^b   Fredman, P ^b   Raiha I ^a   Sourander, L ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cerebrospinal fluid; Ganglioside; Leukoaraiosis; Sulfatide; White matter low attenuation

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GD3; GANGLIOSIDE GM1; GANGLIOSIDE GT 1B; SULFATIDE;

AGED; ARTICLE; BRAIN INFARCTION; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMYELINATION; FEMALE; GLIOSIS; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; NERVE CELL DEGENERATION; PRIORITY JOURNAL;

EID: 0030935442     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106628     Document Type: Article

References (27)

1. Erkinjuntti T, Sulkava R, Palo J, Ketonen L: CT in the differential diagnosis between Alzheimer's disease and vascular dementia. Acta Neurol Scand 1987;75:262-270.
2. Hachinski V, Potter P, Merskey H: Leuko-araiosis. Arch Neurol 1987;44:21-23.
3. Blennow K, Wallin A, Uhlemann C, Gottfries CG: White-matter lesions on CT in Alzheimer patients: Relation to clinical Symptomatologie and vascular factors. Acta Neurol Scand 1991; 83:187-193.
4. Erkinjuntti T: Dementia. Clinical diagnosis and differential diagnosis with special reference to multi-infarct dementia; University of Helsinki. 1988.
5. Bots ML, van Swieten JC, Breteler MM, de Jong PT, van Gijn J, Hofman A, Grobbee DE: Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 1993;341: 1232-1237.
6. Erkinjuntti T. Hachinski VC: Rethinking vascular dementia. Cerebrovasc Dis 1993;3:3-23.
7. Brun A, Englund E: A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Ann Neurol 1986;19:253-262.
8. Wallin A, Gottfries CG, Karlsson I, Svenner-holm L: Decreased myelin lipids in Alzheimer’s disease and vascular dementia. Acta Neurol Scand 1989;80:319-323.
9. Janota I, Mirsen TR, Hachinski VC, Lee DH, Merskey H: Neuropathologie correlates of leu-ko-araiosis. Arch Neurol 1989;46:1124-1128.
10. Doljanski F, Kapeller M: Cell surface shedding - the phenomenon and its possible significance. J Theor Biol 1976;62:253-270.
11. Svennerholm L: Structure and biology of cell membrane gangliosides; in Ouchtcrlony Ö. Holmgren J (eds): Cholera and Related Diarrheas. 43rd Nobel Symp, Stockholm 1978. Basel, Karger. 1980, pp 80-87.
12. Suzuki K: The pattern of mammalian brain gangliosides - III: Regional and developmental differences. J Neurochem 1965:12:969-979.
13. Ledeen RW, Skrivanek JA, Tirri U. Margolis RK, Margolis RU: Gangliosides of the neuron: Localization and origin. Adv Exp Med Biol 1976;71:83-103.
14. Wiegandt H: The subcellular localisation of gangliosides in the brain. J Neurochem 1967: 14:671-674.
15. Breckenridge WC, Gombos G, Morgan IG: The lipid composition of adult and rat brain synaptosomal plasma membranes. Biochim BiophysActa 1972:266:695-707.
16. Davidsson P, Fredman P, Svennerholm L: Gangliosides and sulphatide in human cerebrospinal fluid: Quantitation with immunoaffinity techniques. J Chromatogr 1989;496:279-289.
17. Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Karlsson I, Mansson JE, Svennerholm L: Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease’. Arch Neurol 1991:48:1032-1035.
18. Raff MC, Fields KL. Hakomori S-I. Mirsky R. Pruss RM, Winter J: Cell-type-specific markers for distinguishing and studying neurons and the major classes of glia cells in culture. Brain Res 1979;174:283-308.
19. Wallin A. Blennow K: Pathogenetic basis of multi-infarct dementia. Alzheimer Dis Assoc Disord 1991;5:91-102.
20. Fredman P, Wallin A, Blennow K, Davidsson P, Gottfries CG, Svennerholm L: Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia. Acta Neurol Scand 1992:85:103-106.
21. Kawai K. Kuroda S. Watarai S. Takahashi H. Ikuta F: Occurrence of GD3 gangliosidc in reactive aslrocytosis - an immunological study in the rat brain. Neurosci Lett 1994; 174:225-227.
22. Sevfried TN, Yu RK: Cerebellar gangliosidc abnormalities in ped mutant mice. J Neurosci Res 1990:26:105-111.
23. McKhann G. Drachman D. Folstein M. Katz-man R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
24. Roma GC, Tatemichi TK, Erkinjunlti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo J-M, Brun A, Holman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Draver BP, Bennett DA, Fisher M, Ogata J, Kokrnen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajcau AK, Bell MA, DeCarli C, Culebras A, Korezyn AD, Bogousslavsky J, Hartman A, Scheinberg P: Vascular dementia: Diagnostic criteria for research studies. Report of the N1NDS-AIREN International Workshop. Neurology 1993:43:250-260.
25. Hachinski VC, Iliff LD, Phil M, et al: Cerebral blood flow in dementia. Arch Neurol 1975:32: 632-637.
26. Tibbling G, Link H, Öhman S: Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977:37:385-390.
27. Davidsson P. Fredman P. Mansson JE. Svennerholm L: Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmuno-affinity technique. Clin Chim Acta 1991:197:105-116.